FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2117974708> ?p ?o ?g. }

• W2117974708 endingPage "81" @default.
• W2117974708 startingPage "75" @default.
• W2117974708 abstract "Purpose Approximately 5% to 20% of patients who undergo total body irradiation (TBI) in preparation for hematopoietic cell transplantation (HCT) can develop extramedullary (EM) relapse. Whereas total marrow and lymphoid irradiation (TMLI) provides a more conformally targeted radiation therapy for patients, organ sparing has the potential to place the patient at a higher risk for EM relapse than TBI. This study evaluated EM relapse in patients treated with TMLI at our institution. Methods and Materials Patients eligible for analysis had been enrolled in 1 of 3 prospective TMLI trials between 2006 and 2012. The TMLI targeted bones, major lymph node chains, liver, spleen, testes, and brain, using image-guided tomotherapy with total dose ranging from 12 to 15 Gy. Results A total of 101 patients with a median age of 47 years were studied. The median follow-up was 12.8 months. Incidence of EM relapse and bone marrow (BM) relapse were 12.9% and 25.7%, respectively. Of the 13 patients who had EM relapse, 4 also had BM relapse, and 7 had EM disease prior to HCT. There were a total of 19 EM relapse sites as the site of initial recurrence: 11 soft tissue, 6 lymph node, 2 skin. Nine of these sites were within the target region and received ≥12 Gy. Ten initial EM relapse sites were outside of the target region: 5 sites received 10.1 to 11.4 Gy while 5 sites received <10 Gy. Pretransplantation EM was the only significant predictor of subsequent EM relapse. The cumulative incidence of EM relapse was 4% at 1 year and 11.4% at 2 years. Conclusions EM relapse incidence was as frequent in regions receiving ≥10 Gy as those receiving <10 Gy. EM relapse rates following TMLI that included HCT regimens were comparable to published results with regimens including TBI and suggest that TMLI is not associated with an increased EM relapse risk. Approximately 5% to 20% of patients who undergo total body irradiation (TBI) in preparation for hematopoietic cell transplantation (HCT) can develop extramedullary (EM) relapse. Whereas total marrow and lymphoid irradiation (TMLI) provides a more conformally targeted radiation therapy for patients, organ sparing has the potential to place the patient at a higher risk for EM relapse than TBI. This study evaluated EM relapse in patients treated with TMLI at our institution. Patients eligible for analysis had been enrolled in 1 of 3 prospective TMLI trials between 2006 and 2012. The TMLI targeted bones, major lymph node chains, liver, spleen, testes, and brain, using image-guided tomotherapy with total dose ranging from 12 to 15 Gy. A total of 101 patients with a median age of 47 years were studied. The median follow-up was 12.8 months. Incidence of EM relapse and bone marrow (BM) relapse were 12.9% and 25.7%, respectively. Of the 13 patients who had EM relapse, 4 also had BM relapse, and 7 had EM disease prior to HCT. There were a total of 19 EM relapse sites as the site of initial recurrence: 11 soft tissue, 6 lymph node, 2 skin. Nine of these sites were within the target region and received ≥12 Gy. Ten initial EM relapse sites were outside of the target region: 5 sites received 10.1 to 11.4 Gy while 5 sites received <10 Gy. Pretransplantation EM was the only significant predictor of subsequent EM relapse. The cumulative incidence of EM relapse was 4% at 1 year and 11.4% at 2 years. EM relapse incidence was as frequent in regions receiving ≥10 Gy as those receiving <10 Gy. EM relapse rates following TMLI that included HCT regimens were comparable to published results with regimens including TBI and suggest that TMLI is not associated with an increased EM relapse risk." @default.
• W2117974708 created "2016-06-24" @default.
• W2117974708 creator A5004910687 @default.
• W2117974708 creator A5014867897 @default.
• W2117974708 creator A5020684790 @default.
• W2117974708 creator A5038274786 @default.
• W2117974708 creator A5039374832 @default.
• W2117974708 creator A5051751172 @default.
• W2117974708 creator A5065938090 @default.
• W2117974708 creator A5071412954 @default.
• W2117974708 creator A5078144938 @default.
• W2117974708 date "2014-05-01" @default.
• W2117974708 modified "2023-10-17" @default.
• W2117974708 title "Extramedullary Relapse Following Total Marrow and Lymphoid Irradiation in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation" @default.
• W2117974708 cites W1274344746 @default.
• W2117974708 cites W1965368938 @default.
• W2117974708 cites W1973177688 @default.
• W2117974708 cites W1973617793 @default.
• W2117974708 cites W2035502715 @default.
• W2117974708 cites W2052548144 @default.
• W2117974708 cites W2053700269 @default.
• W2117974708 cites W2058344214 @default.
• W2117974708 cites W2071579945 @default.
• W2117974708 cites W2076944401 @default.
• W2117974708 cites W2115750869 @default.
• W2117974708 cites W2122657363 @default.
• W2117974708 cites W2141750163 @default.
• W2117974708 cites W2143034151 @default.
• W2117974708 cites W2149566660 @default.
• W2117974708 cites W2150917826 @default.
• W2117974708 cites W2161204667 @default.
• W2117974708 cites W2167685544 @default.
• W2117974708 cites W2264531153 @default.
• W2117974708 cites W4244166141 @default.
• W2117974708 cites W4251178308 @default.
• W2117974708 cites W4377470768 @default.
• W2117974708 cites W71007469 @default.
• W2117974708 doi "https://doi.org/10.1016/j.ijrobp.2014.01.036" @default.
• W2117974708 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24725691" @default.
• W2117974708 hasPublicationYear "2014" @default.
• W2117974708 type Work @default.
• W2117974708 sameAs 2117974708 @default.
• W2117974708 citedByCount "30" @default.
• W2117974708 countsByYear W21179747082014 @default.
• W2117974708 countsByYear W21179747082015 @default.
• W2117974708 countsByYear W21179747082016 @default.
• W2117974708 countsByYear W21179747082017 @default.
• W2117974708 countsByYear W21179747082018 @default.
• W2117974708 countsByYear W21179747082020 @default.
• W2117974708 countsByYear W21179747082021 @default.
• W2117974708 countsByYear W21179747082022 @default.
• W2117974708 countsByYear W21179747082023 @default.
• W2117974708 crossrefType "journal-article" @default.
• W2117974708 hasAuthorship W2117974708A5004910687 @default.
• W2117974708 hasAuthorship W2117974708A5014867897 @default.
• W2117974708 hasAuthorship W2117974708A5020684790 @default.
• W2117974708 hasAuthorship W2117974708A5038274786 @default.
• W2117974708 hasAuthorship W2117974708A5039374832 @default.
• W2117974708 hasAuthorship W2117974708A5051751172 @default.
• W2117974708 hasAuthorship W2117974708A5065938090 @default.
• W2117974708 hasAuthorship W2117974708A5071412954 @default.
• W2117974708 hasAuthorship W2117974708A5078144938 @default.
• W2117974708 hasConcept C109159458 @default.
• W2117974708 hasConcept C120665830 @default.
• W2117974708 hasConcept C121332964 @default.
• W2117974708 hasConcept C126322002 @default.
• W2117974708 hasConcept C141071460 @default.
• W2117974708 hasConcept C142724271 @default.
• W2117974708 hasConcept C181152851 @default.
• W2117974708 hasConcept C2776694085 @default.
• W2117974708 hasConcept C2776713427 @default.
• W2117974708 hasConcept C2776755627 @default.
• W2117974708 hasConcept C2777408962 @default.
• W2117974708 hasConcept C2778880498 @default.
• W2117974708 hasConcept C2780007613 @default.
• W2117974708 hasConcept C2780849966 @default.
• W2117974708 hasConcept C28328180 @default.
• W2117974708 hasConcept C2911091166 @default.
• W2117974708 hasConcept C509974204 @default.
• W2117974708 hasConcept C54355233 @default.
• W2117974708 hasConcept C61511704 @default.
• W2117974708 hasConcept C71924100 @default.
• W2117974708 hasConcept C86803240 @default.
• W2117974708 hasConcept C88879693 @default.
• W2117974708 hasConceptScore W2117974708C109159458 @default.
• W2117974708 hasConceptScore W2117974708C120665830 @default.
• W2117974708 hasConceptScore W2117974708C121332964 @default.
• W2117974708 hasConceptScore W2117974708C126322002 @default.
• W2117974708 hasConceptScore W2117974708C141071460 @default.
• W2117974708 hasConceptScore W2117974708C142724271 @default.
• W2117974708 hasConceptScore W2117974708C181152851 @default.
• W2117974708 hasConceptScore W2117974708C2776694085 @default.
• W2117974708 hasConceptScore W2117974708C2776713427 @default.
• W2117974708 hasConceptScore W2117974708C2776755627 @default.
• W2117974708 hasConceptScore W2117974708C2777408962 @default.
• W2117974708 hasConceptScore W2117974708C2778880498 @default.
• W2117974708 hasConceptScore W2117974708C2780007613 @default.
• W2117974708 hasConceptScore W2117974708C2780849966 @default.

• next